Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Also known as: Relapse or Refractory Chronic Lymphocytic Leukemia / Refractory/Relapsed Chronic Lymphocytic Leukemia / Relapsed/Refractory Chronic Lymphocytic Leukemia / Relapsed or Refractory Chronic Lymphocytic Leukemia / Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00098 | Antithymocyte immunoglobulin (rabbit) | 1 | Completed | 1 |
| DB15425 | CYC-065 | 1 | Completed | 1 |
| DB00631 | Clofarabine | 1 | Completed | 1 |
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 | Recruiting | 1 |
| DB16666 | Ianalumab | 1 | Terminated | 1 |
| DB17556 | S65487 | 1 | Completed | 1 |
| DB11581 | Venetoclax | 1 | Completed | 1 |
| DB00531 | Cyclophosphamide | 1 / 2 | Recruiting | 1 |
| DB00997 | Doxorubicin | 1 / 2 | Recruiting | 1 |
| DB16672 | Epcoritamab | 1 / 2 | Recruiting | 1 |
| DB00480 | Lenalidomide | 1 / 2 | Recruiting | 1 |
| DB00635 | Prednisone | 1 / 2 | Recruiting | 1 |
| DB00073 | Rituximab | 1 / 2 | Recruiting | 1 |
| DB11581 | Venetoclax | 1 / 2 | Recruiting | 1 |
| DB00541 | Vincristine | 1 / 2 | Recruiting | 1 |
| DB09331 | Daratumumab | 2 | Active Not Recruiting | 1 |
| DB09053 | Ibrutinib | 2 | Active Not Recruiting | 3 |
| DB00480 | Lenalidomide | 2 | Completed | 1 |
| DB00135 | Tyrosine | 2 | Active Not Recruiting | 1 |
| DB11581 | Venetoclax | 2 | Active Not Recruiting | 1 |
| DB15035 | Zanubrutinib | 2 | Completed | 1 |
| DB09053 | Ibrutinib | 3 | Completed | 1 |
| DB06650 | Ofatumumab | 3 | Completed | 1 |
| DB15499 | Cerdulatinib | Not Available | No Longer Available | 1 |